{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:47:04Z","timestamp":1792511224726,"version":"4.5.0"},"reference-count":75,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15105","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:35:28Z","timestamp":1747913728000},"page":"1-13","source":"Crossref","is-referenced-by-count":3,"title":["Prognosis and influencing factors of patients with different lymph node statuses after pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer"],"prefix":"10.3892","volume":"30","author":[{"given":"Jianxi","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine\u2011Hebei Province, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine\u2011Hebei Province, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine\u2011Hebei Province, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine\u2011Hebei Province, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine\u2011Hebei Province, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine\u2011Hebei Province, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine\u2011Hebei Province, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine\u2011Hebei Province, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Chemotherapy, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine East Ward, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"key20250611125830_b1-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"1","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"key20250611125830_b2-ol-30-1-15105","first-page":"124","article-title":"Tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Influencing factors and prognostic significance","volume":"16","author":"Lu","year":"2023","journal-title":"Int J Clin Exp Pathol"},{"key":"key20250611125830_b3-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Glynne-Jones","year":"2018","journal-title":"Ann Oncol"},{"key":"key20250611125830_b4-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"874","DOI":"10.6004\/jnccn.2018.0021","article-title":"Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Benson","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"key20250611125830_b5-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.ijrobp.2015.08.037","article-title":"A randomized phase 2 study of neoadjuvant chemoradiaton therapy with 5-fluorouracil\/leucovorin or irinotecan\/S-1 in patients with locally advanced rectal cancer","volume":"93","author":"Jung","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250611125830_b6-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4174\/astr.2023.105.6.341","article-title":"Unveiling the profound advantages of total neoadjuvant therapy in rectal cancer: A trailblazing exploration","volume":"105","author":"Jung","year":"2023","journal-title":"Ann Surg Treat Res"},{"key":"key20250611125830_b7-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1300535","DOI":"10.3389\/fonc.2023.1300535","article-title":"Radiotherapy in the preoperative neoadjuvant treatment of locally advanced rectal cancer","volume":"13","author":"Yu","year":"2023","journal-title":"Front Oncol"},{"key":"key20250611125830_b8-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00384-017-2939-9","article-title":"Pretreatment identification of patients likely to have pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer","volume":"33","author":"van der Sluis","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"key20250611125830_b9-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"443","DOI":"10.34172\/mejdd.2022.306","article-title":"Predicting factors of complete pathological response in locally advanced rectal cancer","volume":"14","author":"Latif","year":"2022","journal-title":"Middle East J Dig Dis"},{"key":"key20250611125830_b10-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1097\/SLA.0000000000000462","article-title":"Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01)","volume":"265","author":"Smith","year":"2017","journal-title":"Ann Surg"},{"key":"key20250611125830_b11-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"7145","DOI":"10.1038\/s41598-022-10974-7","article-title":"Clinical prediction model of pathological response following neoadjuvant chemoradiotherapy for rectal cancer","volume":"12","author":"Shin","year":"2022","journal-title":"Sci Rep"},{"key":"key20250611125830_b12-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1200\/jco.2005.23.16_suppl.3505","article-title":"Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results-EORTC 22921","volume":"23","author":"Bosset","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20250611125830_b13-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1200\/JCO.2007.15.3858","article-title":"Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer","volume":"26","author":"Braendengen","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20250611125830_b14-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.surg.2021.10.003","article-title":"Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patients","volume":"171","author":"Collard","year":"2022","journal-title":"Surgery"},{"key":"key20250611125830_b15-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00428-018-2409-y","article-title":"HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: The relationship with molecular results and clinicopathologic features","volume":"473","author":"Park","year":"2018","journal-title":"Virchows Arch"},{"key":"key20250611125830_b16-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20250611125830_b17-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.surg.2011.08.013","article-title":"CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer","volume":"151","author":"Jo","year":"2012","journal-title":"Surgery"},{"key":"key20250611125830_b18-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"106974","DOI":"10.1016\/j.phrs.2023.106974","article-title":"Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"197","author":"Zhang","year":"2023","journal-title":"Pharmacol Res"},{"key":"key20250611125830_b19-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"key20250611125830_b20-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.21873\/anticanres.13705","article-title":"Complete pathological response following radiochemotherapy for locally advanced rectal cancer: Short and long-term outcome","volume":"39","author":"Iskander","year":"2019","journal-title":"Anticancer Res"},{"key":"key20250611125830_b21-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijrobp.2007.12.019","article-title":"Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients","volume":"72","author":"Capirei","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250611125830_b22-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.7150\/ijbs.15438","article-title":"A Review of neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"12","author":"Li","year":"2016","journal-title":"Int J Biol Sci"},{"key":"key20250611125830_b23-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/jso.26247","article-title":"Ten-year survival after pathologic complete response in rectal adenocarcinoma","volume":"123","author":"Sell","year":"2021","journal-title":"J Surg Oncol"},{"key":"key20250611125830_b24-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1245\/s10434-010-1506-1","article-title":"Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence","volume":"18","author":"de Campos-Lobato","year":"2011","journal-title":"Ann Surg Oneol"},{"key":"key20250611125830_b25-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijrobp.2007.12.019","article-title":"Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients","volume":"72","author":"Capirci","year":"2008","journal-title":"Int J Radiat Oneol Biol Phys"},{"key":"key20250611125830_b26-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12876-022-02226-9","article-title":"Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection","volume":"22","author":"Zeman","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"key20250611125830_b27-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s13304-020-00841-3","article-title":"The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer","volume":"72","author":"Li Destri","year":"2020","journal-title":"Updates Surg"},{"key":"key20250611125830_b28-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.31557\/APJCP.2021.22.5.1607","article-title":"Predictive factors for pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer","volume":"22","author":"Zhang","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20250611125830_b29-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cpt.2023.01.001","article-title":"Examined lymph node numbers influence prognosis in rectal cancer treated with neoadjuvant therapy","volume":"1","author":"Zhu","year":"2023","journal-title":"Cancer Pathog Ther"},{"key":"key20250611125830_b30-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/his.15134","article-title":"Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer","volume":"84","author":"Ozturk","year":"2024","journal-title":"Histopathology"},{"key":"key20250611125830_b31-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"272","DOI":"10.21147\/j.issn.1000-9604.2018.02.10","article-title":"Long-term outcomes in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy and curative resection","volume":"30","author":"Lu","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"key20250611125830_b32-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"E190","DOI":"10.1111\/ans.16544","article-title":"Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer","volume":"91","author":"Zhang","year":"2021","journal-title":"ANZ J Surg"},{"key":"key20250611125830_b33-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Trackingthe evolution of non-small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N Engl J Med"},{"key":"key20250611125830_b34-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature25161","article-title":"Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"554","author":"Abbosh","year":"2018","journal-title":"Nature"},{"key":"key20250611125830_b35-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1245\/s10434-015-5017-y","article-title":"Predictors of pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer","volume":"23","author":"Al-Sukhni","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"key20250611125830_b36-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"449","DOI":"10.6061\/clinics\/2016(08)07","article-title":"Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer","volume":"71","author":"Peng","year":"2016","journal-title":"Clinics (Sao Paulo)"},{"key":"key20250611125830_b37-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"key20250611125830_b38-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1125470","DOI":"10.3389\/fonc.2023.1125470","article-title":"Assessing the predictive value of clinical factors to pathological complete response for locally advanced rectal cancer: An analysis of 124 patients","volume":"13","author":"Zhou","year":"2023","journal-title":"Front Oncol"},{"key":"key20250611125830_b39-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12032-017-1037-8","article-title":"Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: A systematic review and meta-analysis","volume":"34","author":"Colloca","year":"2017","journal-title":"Med Oncol"},{"key":"key20250611125830_b40-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3390\/cells12030413","article-title":"Promises and challenges of predictive blood biomarkers for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"12","author":"Machado Carvalho","year":"2023","journal-title":"Cells"},{"key":"key20250611125830_b41-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1186\/s12885-024-13328-w","article-title":"Pathomics-based machine learning models for predicting pathological complete response and prognosis in locally advanced rectal cancer patients post-neoadjuvant chemoradiotherapy: Insights from two independent institutional studies","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cancer"},{"key":"key20250611125830_b42-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00520-024-08860-1","article-title":"A large population-based and validated study on the follow-up management and supportive strategy of locally advanced rectal cancer patients","volume":"32","author":"Yu","year":"2024","journal-title":"Support Care Cancer"},{"key":"key20250611125830_b43-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41416-024-02790-9","article-title":"Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy","volume":"131","author":"Bengala","year":"2024","journal-title":"Br J Cancer"},{"key":"key20250611125830_b44-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12876-025-03615-6","article-title":"Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer","volume":"25","author":"Zheng","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"key20250611125830_b45-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/cancers15051469","article-title":"Predictive and prognostic value of oncogene mutations and microsatellite instability in locally-advanced rectal cancer treated with neoadjuvant radiation-based therapy: A systematic review and meta-analysis","volume":"15","author":"De Mattia","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20250611125830_b46-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/his.14710","article-title":"Microsatellite instability in rectal cancer: What does it mean? A study of two randomized trials and a systematic review of the literature","volume":"81","author":"Swets","year":"2022","journal-title":"Histopathology"},{"key":"key20250611125830_b47-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1111\/jcmm.16547","article-title":"Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"},{"key":"key20250611125830_b48-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N Engl J Med"},{"key":"key20250611125830_b49-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1200\/JCO.24.01160","article-title":"Management of locally advanced rectal cancer: ASCO guideline","volume":"42","author":"Scott","year":"2024","journal-title":"J Clin Oncol"},{"key":"key20250611125830_b50-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1200\/JCO.2017.76.2187","article-title":"FOLFOX or CAPOX in stage II to III colon cancer: Efficacy results of the Italian three or six colon adjuvant trial","volume":"36","author":"Sobrero","year":"2018","journal-title":"J Clin Oncol"},{"key":"key20250611125830_b51-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(23)00219-X","article-title":"First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): An open-label, multicentre, randomised, controlled, phase 3 study from the Dutch colorectal cancer group","volume":"24","author":"Bond","year":"2023","journal-title":"Lancet Oncol"},{"key":"key20250611125830_b52-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3322\/caac.21728","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine","volume":"72","author":"Ciardiello","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"key20250611125830_b53-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/ags3.12853","article-title":"Essential updates 2022\u20132023: Surgical and adjuvant therapies for locally advanced colorectal cancer","volume":"8","author":"Kajiwara","year":"2024","journal-title":"Ann Gastroenterol Surg"},{"key":"key20250611125830_b54-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMe2031294","article-title":"Pembrolizumab in MSI-H-dMMR advanced colorectal cancer-A new standard of care","volume":"383","author":"Grothey","year":"2020","journal-title":"N Engl J Med"},{"key":"key20250611125830_b55-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci Transl Med"},{"key":"key20250611125830_b56-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/gutjnl-2014-308859","article-title":"Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery","volume":"65","author":"Reinert","year":"2016","journal-title":"Gut"},{"key":"key20250611125830_b57-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/diagnostics11030516","article-title":"CEA, EpCAM, \u03b1v\u03b26 and uPAR expression in rectal cancer patients with a pathological complete response after neoadjuvant therapy","volume":"11","author":"Linders","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"key20250611125830_b58-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.2147\/OTT.S145473","article-title":"Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy","volume":"11","author":"Boogerd","year":"2018","journal-title":"Onco Targets Ther"},{"key":"key20250611125830_b59-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"101897","DOI":"10.4240\/wjgs.v17.i2.101897","article-title":"Predictive value of magnetic resonance imaging parameters combined with tumor markers for rectal cancer recurrence risk after surgery","volume":"17","author":"Wu","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"key20250611125830_b60-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.3390\/ijms21197040","article-title":"The role of Micro-RNAs and circulating tumor markers as predictors of response to neoadjuvant therapy in locally advanced rectal cancer","volume":"21","author":"De Palma","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20250611125830_b61-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/s41591-022-01930-z","article-title":"Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer","volume":"28","author":"Chatila","year":"2022","journal-title":"Nat Med"},{"key":"key20250611125830_b62-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.7150\/thno.37794","article-title":"Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy","volume":"9","author":"Yang","year":"2019","journal-title":"Theranostics"},{"key":"key20250611125830_b63-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"key20250611125830_b64-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ijc.34880","article-title":"Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer","volume":"155","author":"Hammarstr\u00f6m","year":"2024","journal-title":"Int J Cancer"},{"key":"key20250611125830_b65-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1158\/2159-8290.CD-17-1226","article-title":"Combined BRAF, EGFR, and MEK inhibition in patients with BRAFV600E-mutant colorectal cancer","volume":"4","author":"Corcoran","year":"2018","journal-title":"Cancer Discov"},{"key":"key20250611125830_b66-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/SLA.0000000000003051","article-title":"Microsatellite instability (MSI) as an independent predictor of pathologic complete response (PCR) in locally advanced rectal cancer: A national cancer database (NCDB) analysis","volume":"271","author":"Hasan","year":"2020","journal-title":"Ann Surg"},{"key":"key20250611125830_b67-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/sj.bjc.6604867","article-title":"Deficient mismatch repair system in patients with sporadic advanced colorectal cancer","volume":"100","author":"Koopman","year":"2009","journal-title":"Br J Cancer"},{"key":"key20250611125830_b68-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s13304-019-00697-2","article-title":"Do microsatellite instability (MSI) and deficient mismatch repair (dMMR) affect the pathologic complete response (pCR) in patients with rectal cancer who received neoadjuvant treatment?","volume":"72","author":"Acar","year":"2020","journal-title":"Updates Surg"},{"key":"key20250611125830_b69-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"e237096","DOI":"10.6004\/jnccn.2023.7096","article-title":"Long-term outcomes of dMMR\/MSI-H rectal cancer treated with anti-PD-1-based immunotherapy as curative-intent treatment","volume":"22","author":"Yu","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"key20250611125830_b70-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/DCR.0000000000000321","article-title":"Size and distribution of lymph nodes in rectal cancer resection specimens","volume":"4","author":"Langman","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"key20250611125830_b71-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/codi.16875","article-title":"Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: Results from a multicentre international cohort study","volume":"26","author":"Achilli","year":"2024","journal-title":"Colorectal Dis"},{"key":"key20250611125830_b72-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.surg.2014.10.010","article-title":"Pathologic evaluation of the response of mesorectal positive nodes to preoperative chemoradiotherapy in patients with rectal cancer","volume":"157","author":"Beppu","year":"2015","journal-title":"Surgery"},{"key":"key20250611125830_b73-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/medicina57101044","article-title":"Evaluation and predictive factors of complete response in rectal cancer after neoadjuvant chemoradiation therapy","volume":"57","author":"Kokaine","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"key20250611125830_b74-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/ajg.2011.301","article-title":"Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?","volume":"106","author":"Yuhara","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"key20250611125830_b75-ol-30-1-15105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12885-020-06761-0","article-title":"Risk factor analysis for inaccurate pre-operative MRI staging in rectal cancer","volume":"20","author":"Cai","year":"2020","journal-title":"BMC Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:58:37Z","timestamp":1749635917000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,22]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15105","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}